Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   ACTAVIS
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
ACTAVIS
Dec-18
ALKEM LABORATORIES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,62516,126-   
Low Rs2,83510,818-   
Sales per share (Unadj.) Rs970.13,955.8-  
Earnings per share (Unadj.) Rs84.2-1,274.2-  
Cash flow per share (Unadj.) Rs110.2416.9-  
Dividends per share (Unadj.) Rs50.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs756.416,315.7-  
Shares outstanding (eoy) m119.57332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.33.4 97.8%   
Avg P/E ratio x38.4-10.6 -362.8%  
P/CF ratio (eoy) x29.332.3 90.7%  
Price / Book Value ratio x4.30.8 517.1%  
Dividend payout %59.40-   
Avg Mkt Cap Rs m386,2074,480,758 8.6%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m21,3140-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m115,9931,315,689 8.8%  
Other income Rs m2,16125,160 8.6%   
Total revenues Rs m118,1531,340,849 8.8%   
Gross profit Rs m15,06534,478 43.7%  
Depreciation Rs m3,104562,428 0.6%   
Interest Rs m1,07475,923 1.4%   
Profit before tax Rs m13,048-578,713 -2.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m2,980-7,334 -40.6%   
Profit after tax Rs m10,068-423,784 -2.4%  
Gross profit margin %13.02.6 495.6%  
Effective tax rate %22.81.3 1,802.0%   
Net profit margin %8.7-32.2 -26.9%  
BALANCE SHEET DATA
Current assets Rs m86,064539,627 15.9%   
Current liabilities Rs m37,071477,372 7.8%   
Net working cap to sales %42.24.7 892.7%  
Current ratio x2.31.1 205.4%  
Inventory Days Days3320 166.4%  
Debtors Days Days6766 101.2%  
Net fixed assets Rs m37,245148,929 25.0%   
Share capital Rs m2390-   
"Free" reserves Rs m90,2080-   
Net worth Rs m90,4475,426,601 1.7%   
Long term debt Rs m01,910,903 0.0%   
Total assets Rs m124,5418,483,012 1.5%  
Interest coverage x13.2-6.6 -198.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.2 600.5%   
Return on assets %8.9-4.1 -218.2%  
Return on equity %11.1-7.8 -142.5%  
Return on capital %15.6-4.8 -322.5%  
Exports to sales %14.60-   
Imports to sales %00-   
Net fx Rs m12,7270-   
CASH FLOW
From Operations Rs m16,825470,046 3.6%  
From Investments Rs m1,128258,229 0.4%  
From Financial Activity Rs m-17,608-806,740 2.2%  
Net Cashflow Rs m416-78,073 -0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ALKEM LABORATORIES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: TWILIGHT LITAKA PH.  EVEREST ORGANICS  BETA DRUGS   SOURCE NATURAL FOODS  NUTRAPLUS PR  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.